drugset / Trial / NCT05347576
A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions
RandomizedCrossoverOpen-labelTreatment
Summary
A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions
Timeline
- Start
- 2022-04-21
- Primary completion
- 2022-05-02
- Completion
- 2022-05-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CKD-393(2) | Unknown | — | Oral |
| Subject | D029 | Unknown | — | Oral |
| Subject | D150 | Unknown | — | Oral |
| Subject | D759 | Unknown | — | Oral |
| Subject | Lobeglitazone | Small molecule | — | Oral |